Trilostane
규격
13647-35-3CAS 번호
237-133-0EC 번호
(1S,2R,6R,8S,11S,12S,15S,16S)-5,15-dihydroxy-2,16-dimethyl-7-oxapentacyclo[9.7.0.02,8.06,8.012,16]octadec-4-ene-4-carbonitrileIUPAC 명칭
C20H27NO3화학식
329.4 g/mol분자량
Trilostane; 13647-35-3; Modrenal; Vetoryl; Desopan; Modrastane; Trilostano; Win-24540; Trilostanum; DTXSID9023706; WIN 24,540; L0FPV48Q5R; Win 24540; CHEBI:32260; NSC-758904; Androst-2-ene-2-carbonitrile, 4,5-epoxy-3,17-dihydroxy-, (4alpha,5alpha,17beta)-; DTXCID103706; (1S,2R,6R,8S,11S,12S,15S,16S)-5,15-dihydroxy-2,16-dimethyl-7-oxapentacyclo[9.7.0.0^{2,8}.0^{6,8}.0^{12,16}]octadec-4-ene-4-carbonitrile; (1S,2R,6R,8S,11S,12S,15S,16S)-5,15-dihydroxy-2,16-dimethyl-7-oxapentacyclo(9.7.0.0^(2,8).0^(6,8).0^(12,16))octadec-4-ene-4-carbonitrile; VETORYL CAPSULES; RefChem:56170; 4alpha,5-epoxy-17beta-hydroxy-3-oxoandrostane-2-carbonitrile; 2Alpha-cyano-4alpha,5alpha-epoxyandrostan-17beta-ol-3-one; (4Alpha,5alpha,17beta)-4,5-epoxy-3,17-dihydroxyandrost-2-ene-2-carbonitrile; 237-133-0; 4,5-Epoxy-17-hydroxy-3-oxoandrostane-2-carbonitrile; MFCD00199295; (1S,2R,6R,8S,11S,12S,15S,16S)-5,15-dihydroxy-2,16-dimethyl-7-oxapentacyclo[9.7.0.02,8.06,8.012,16]octadec-4-ene-4-carbonitrile; 4alpha,5-Epoxy-3,17beta-dihydroxy-5alpha-androst-2-ene-2-carbonitrile; (1aR,4aR,4bS,6aS,7S,9aS,9bS,11aS)-2,7-dihydroxy-4a,6a-dimethyl-1a,4,4a,4b,5,6,6a,7,8,9,9a,9b,10,11-tetradecahydrocyclopenta[7,8]phenanthro[1,10a-b]oxirene-3-carbonitrile; Modrenal (TN); Desopan (TN); CAS-13647-35-3; Trilostane (JAN/USAN); Trilostanum [INN-Latin]; Trilostano [INN-Spanish]; UNII-L0FPV48Q5R; (4alpha,5alpha,17beta)-3,17-dihydroxy-4,5-epoxyandrost-2-ene-2-carbonitrile; Androst-2-ene-2-carbonitrile, 4,5-epoxy-3,17-dihydroxy-, (4.alpha.,5.alpha.,17.beta.)-; KVJXBPDAXMEYOA-CXANFOAXSA-N; Trilostane [USAN:INN:BAN:JAN]; NCGC00274061-01; EINECS 237-133-0; WIN 24450; Trilostane (Standard); TRILOSTANE [MI]; TRILOSTANE [INN]; TRILOSTANE [JAN]; TRILOSTANE [USAN]; TRILOSTANE [VANDF]; Androst-2-ene-2-carbonitrile, 4,5-epoxy-3,17-dihydroxy-, (4a,5a,17b)-; SCHEMBL7517; TRILOSTANE [MART.]; TRILOSTANE [WHO-DD]; GTPL6850; orb1308537; Trilostane - Bio-X trade mark; TRILOSTANE [GREEN BOOK]; CHEMBL1200907; TRILOSTANE [ORANGE BOOK]; Trilostane, >=98% (HPLC); GLXC-06572; HMS3884A15; Tox21_112454; Tox21_302406; 4-alpha,5-Epoxy-3,17-dihydroxy-5-alpha-androst-2-ene-2-carbonitrile; AC-927; BDBM50247882; EBC-11126; HY-14281R; s1404; 3,17beta-dihydroxy-4alpha,5-epoxy-5alpha-androst-2-ene-2-carbonitrile; AKOS015964043; AKOS032947221; Tox21_112454_1; Trilostane(Win 24540; Modrastane)?; CCG-267803; CS-1707; DB01108; FT28510; KS-1414; NSC 758904; (2-alpha,4-alpha,5-alpha,17-beta)-4,5-Epoxy-17-hydroxy-3-oxoandrostane-2-carbonitrile; 4-alpha-5-Epoxy-17-beta-hydroxy-3-oxo-5-alpha-androstane-2-alpha-carbonitrile; Androstane-2-carbonitrile, 4,5-epoxy-17-hydroxy-3-oxo-, (2-alpha,4-alpha,5-alpha,17-beta)-; NCGC00255201-01; NCGC00274061-04; (1aR,4aR,4bS,6aS,7S,9aS,9bS,11aS)-2,7-dihydroxy-4a,6a-dimethyl-1a,4,4a,4b,5,6,6a,7,8,9,9a,9b,10,11-tetradecahydrocyclopenta[7,8]phenanthro[1,10a-b]oxirene-3-carbonitrile.; BT300134; HY-14281; SY046020; NS00018304; D01180; EN300-122374; AB01274788-01; AB01274788_02; Q907313; Z1541759903; Trilostane; 13647-35-3; Vetoryl; Modrenal; Modrastane; 3,17beta-Dihydroxy-4alpha,5alpha-4,5-epoxyandrost-2-ene-2-carbonitrile; (2-alpha,4-alpha,5-alpha,17-beta)-4,5-epoxy-17-hydroxy-3-oxoandrostane-2-car; 5-alpha-ANDROSTANE-2-alpha-CARBONITRILE, 4-alpha,5-EPOXY-17-beta-HYDROXY-3-OXO-; Androst-2-ene-2-carbonitrile, 4,5-epoxy-3,17-dihydroxy-, (4|A,5|A,17|A)-; (1S,2R,6R,8S,11S,12S,15S,16S)-2,16-dimethyl-5,15-bis(oxidanyl)-7-oxapentacyclo[9.7.0.02,8.06,8.012,16]octadec-4-ene-4-carbonitrile동의어
Trilostane 함유 제품
デソパン錠60mgTrilostane - ChemWerth IncTrilostane - Henan Lihua PharmaceuticalTrilostaneTrilostane13647-35-3TrilostaneTrilostane/Trilostane (can be used to treat breast cancer and dog Cushing's syndrome)TRILOSTANETrilostaneTrilostaneTrilostaneTrilostane
1/2 페이지
Trilostane 판매 기업
LP
Liaoning Pharmaceutical Innovation Co., Ltd. ChinaHD
Hangzhou Dingyan Chem Co., LtdChinaSR
Shanghai Record Pharmaceuticals Co., Ltd.ChinaLP
Liaoning Pharmaceutical Innovation Co.. Ltd.ChinaTE
TIANJIN ENJU BIOTECHNOLOGY CO., LTD.ChinaHS
Hepta Sciences Co,. Limited持田
持田製薬株式会社JapanLE
Lifocos Enterprise Co LtdChina1/2 페이지